Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial

Priscilla GUGLIELMO, Elisabetta PERRONE, Pınar P. ÖZCAN, Paola MAPELLI, Angelo PORRECA, Esra ARSLAN, Laura EVANGELISTA

Open source

DOI
10.23736/s1824-4785.26.03687-3
Published
2026-07
Container
The Quarterly Journal of Nuclear Medicine and Molecular Imaging
Publisher
Edizioni Minerva Medica
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.23736/s1824-4785.26.03687-3,
  title = {Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial},
  author = {Priscilla GUGLIELMO and Elisabetta PERRONE and Pınar P. ÖZCAN and Paola MAPELLI and Angelo PORRECA and Esra ARSLAN and Laura EVANGELISTA},
  year = {2026},
  journal = {The Quarterly Journal of Nuclear Medicine and Molecular Imaging},
  doi = {10.23736/s1824-4785.26.03687-3},
  url = {https://doi.org/10.23736/s1824-4785.26.03687-3}
}

RIS

TY  - JOUR
TI  - Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial
AU  - Priscilla GUGLIELMO
AU  - Elisabetta PERRONE
AU  - Pınar P. ÖZCAN
AU  - Paola MAPELLI
AU  - Angelo PORRECA
AU  - Esra ARSLAN
AU  - Laura EVANGELISTA
PY  - 2026
JO  - The Quarterly Journal of Nuclear Medicine and Molecular Imaging
DO  - 10.23736/s1824-4785.26.03687-3
UR  - https://doi.org/10.23736/s1824-4785.26.03687-3
ER  - 

APA

GUGLIELMO, P., PERRONE, E., ÖZCAN, P. P., MAPELLI, P., PORRECA, A., ARSLAN, E., & EVANGELISTA, L. (2026). Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.23736/s1824-4785.26.03687-3

Source records